Clinical Trial: A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06873542) titled 'A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors' on March 07.

Brief Summary: This trial employs a non-randomized, open-label, dose-escalation design to evaluate the safety, tolerability, pharmacokinetic (PK) profile, and preliminary efficacy of DC05F01 in Chinese patients with advanced or metastatic solid tumors.

Study Start Date: July 08, 2022

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: DC05F01

DC05F01 capsule

Recruitment Status: COMPLETED

Sponsor: Heronova Pharmaceuticals

Published by HT Digital Content Services with permission from Health Daily Digest....